REG - Feedback PLC - Director Appointment

FeedbackAnnouncement

29/11/2021 13:40

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20211129:nRSc9144Ta&default-theme=true

RNS Number : 9144T  Feedback PLC  29 November 2021

Feedback plc

 

Appointment of Anesh Patel as Chief Financial Officer and Company Secretary

 

Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the specialist clinical
communication company, is pleased to announce that further to previous
announcements, Anesh Patel has been appointed to the board of directors as
Chief Financial Officer and Company Secretary with immediate effect.

 

Anesh Patel was appointed as Chief Financial Officer of Feedback's wholly
owned subsidiary, Feedback Medical Limited, in May 2021 as part of a
succession planning programme following Lindsay Melvin's (Chief Financial
Officer and Company Secretary of Feedback) decision to retire from the board
of Feedback during H2 2021. Anesh has worked alongside Lindsay over the past
months to ensure a smooth and orderly transition.

 

Anesh joined Feedback Medical Limited from hVIVO Limited, a subsidiary of
AIM-listed Open Orphan plc and a rapidly growing, industry-leading, clinical
services provider to pharma, biotech and government organisations where most
recently he was finance & corporate projects director. Prior to hVIVO, he
spent seven years in investment banking where he specialised in corporate
finance advisory services, at leading banks including Société Générale and
Standard Bank. Anesh started his professional career with Ernst & Young in
2004 where he qualified as a chartered accountant, initially working within
the audit & assurance division before transferring to the transaction
support team for private equity clients. He graduated from University College
London (UCL) and holds an M.Sci. (Hons) degree in Mathematics with Economics.

 

Rory Shaw, Chairman of Feedback, commented: "We welcome Anesh to the Board of
Feedback.  He joined the team earlier this year and has already proven the
value he brings through his contribution to the successful £11.2 million
fundraise recently announced.  His broad financial and commercial experience
provides a good balance to the medical and technical expertise we have across
the Board, creating a strong team to take the Company forward.  I would also
like to take this opportunity to thank Lindsay for his work guiding the
Company through its formative years, and for enabling a smooth handover to
ensure Feedback continues on this trajectory of growth.  We believe that
Feedback is set for a bright and exciting future ahead."

 

Aneshkumar (Anesh) Ishwarbhai Patel (aged 40) does not currently hold any
directorships and has no previous directorships (within 5 years). Anesh Patel
has confirmed that there is no further information to be disclosed pursuant to
paragraph (g) of Schedule 2 of the AIM Rules.

 

Enquiries:

 

 Feedback plc                                    +44 (0)1954 718072

 Tom Oakley, CEO                                 IR@fbk.com (mailto:IR@fbk.com)

 Anesh Patel, CFO

 Panmure Gordon (UK) Limited (NOMAD and Broker)  +44 (0)20 7886 2500

 Emma Earl/Freddy Crossley (Corporate Finance)

 Rupert Dearden (Corporate Broking)

 Walbrook PR Ltd                                 Tel: 020 7933 8780 or feedbackplc@walbrookpr.com
                                                 (mailto:feedbackplc@walbrookpr.com)
 Paul McManus/Nick Rome/Nicholas Johnson         07980 541 893 or 07748 325 236 or 07884 664 686

 

Notes to Editors

 

Feedback plc (AIM: FDBK) is a pioneer of regulated clinical communication
products. Its core product, Bleepa, is a revolutionary medical imaging
communications app, providing an easy-to-use, high quality tool to enable
remote and secure communications between front-line clinicians and teams.
Importantly, it is the only CE marked medical imaging communications platform
on the NHSx clinical communications tools framework. Bleepa has unparalleled
functionality for everyday practice and can be accessed from any
internet-connected device, enabling control of patient cases when on the go.

 

Its highly scalable Software as a Service ("SaaS") based revenue model will
provide increasing levels of visibility as the Company grows its customer
base. With a growing distribution base and technology in place, the focus is
on leveraging key relationships in order to drive sales both in the UK and
internationally to all forms of care providers. As a fully certified medical
device, Bleepa aims to disrupt the medical imaging communications market and,
importantly, increase the accuracy and speed of clinical review.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOADKCBBNBDDFDB